NO20004798L - Barbitursyrederivat og forebyggende og terapeutisk middel for ben og brusk inneholdende det samme - Google Patents
Barbitursyrederivat og forebyggende og terapeutisk middel for ben og brusk inneholdende det sammeInfo
- Publication number
- NO20004798L NO20004798L NO20004798A NO20004798A NO20004798L NO 20004798 L NO20004798 L NO 20004798L NO 20004798 A NO20004798 A NO 20004798A NO 20004798 A NO20004798 A NO 20004798A NO 20004798 L NO20004798 L NO 20004798L
- Authority
- NO
- Norway
- Prior art keywords
- substituted
- acid derivative
- barbituric acid
- bone
- group
- Prior art date
Links
- DNZPLHRZXUJATK-UHFFFAOYSA-N 2-sulfanylidene-5-[[5-[2-(trifluoromethyl)phenyl]furan-2-yl]methyl]-1,3-diazinane-4,6-dione Chemical compound FC(F)(F)C1=CC=CC=C1C(O1)=CC=C1CC1C(=O)NC(=S)NC1=O DNZPLHRZXUJATK-UHFFFAOYSA-N 0.000 title abstract 3
- 210000000988 bone and bone Anatomy 0.000 title abstract 2
- 210000000845 cartilage Anatomy 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 229940124597 therapeutic agent Drugs 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000005002 aryl methyl group Chemical group 0.000 abstract 2
- 208000006386 Bone Resorption Diseases 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 230000024279 bone resorption Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
- C07D239/62—Barbituric acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Barbitursyrederivat ifølge formel (I), der R og R1 uavhengig betegner et hydrogenatom, substituert eller usubstituert alkylgruppe eller GI - Ci5 - alkenylgruppe, en substituert eller usubstituert arylmetylgruppe, og substituert eller usubstituert arylgruppe, og R2 betegner en substituert eller usubstituert alkylgruppe eller Ci - C,5 alkenylgruppe, en substituert eller usubstituert arylmetylgruppe, og substituert eller usubstituert arylgruppe. Barbitursyrederivatet ifølge oppfinnelsen har en sterk inhiberende aktivitet på benresorpsjon og er et nyttig j.UiCuy ggcriuc Og terapeutisk iiiiddel for behandling av sykdommer som påvirker ben og brusk.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10100355A JPH11279157A (ja) | 1998-03-27 | 1998-03-27 | バルビツール酸誘導体およびそれらからなる骨・軟骨疾患予防・治療薬 |
| PCT/IB1999/000961 WO1999050252A2 (en) | 1998-03-27 | 1999-03-23 | Barbituric acid derivative and preventive and therapeutic agent for bone and cartilage containing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20004798D0 NO20004798D0 (no) | 2000-09-26 |
| NO20004798L true NO20004798L (no) | 2000-11-20 |
Family
ID=14271794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20004798A NO20004798L (no) | 1998-03-27 | 2000-09-26 | Barbitursyrederivat og forebyggende og terapeutisk middel for ben og brusk inneholdende det samme |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6498164B1 (no) |
| EP (1) | EP1064269A1 (no) |
| JP (1) | JPH11279157A (no) |
| KR (1) | KR20010042182A (no) |
| CN (1) | CN1295565A (no) |
| AU (1) | AU759249B2 (no) |
| BR (1) | BR9909139A (no) |
| CA (1) | CA2324584A1 (no) |
| CZ (1) | CZ20003460A3 (no) |
| EA (1) | EA200000992A1 (no) |
| HU (1) | HUP0101505A3 (no) |
| IL (1) | IL138433A0 (no) |
| NO (1) | NO20004798L (no) |
| NZ (1) | NZ506616A (no) |
| PL (1) | PL343433A1 (no) |
| SK (1) | SK14032000A3 (no) |
| TR (1) | TR200002785T2 (no) |
| WO (1) | WO1999050252A2 (no) |
| YU (1) | YU57800A (no) |
| ZA (1) | ZA200004473B (no) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2006134024A (ru) * | 2004-02-26 | 2008-04-10 | Инотек Фармасьютикалз Корпорейшн (Us) | Тетрациклические производные лактама и их использование |
| CN102070623B (zh) * | 2010-12-20 | 2012-07-25 | 新乡医学院 | 一种巴比妥酸衍生物及其制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2921072A (en) * | 1956-10-18 | 1960-01-12 | Jr Edgar A Ferguson | Nicotinic acid substituents of barbituric acid |
| GB1339748A (en) * | 1970-07-02 | 1973-12-05 | Ici Ltd | Pyrimidine derivatives |
| JPS5829281B2 (ja) * | 1974-06-04 | 1983-06-22 | 日本曹達株式会社 | バルビツ−ル酸系除草剤 |
| US4695673A (en) * | 1985-11-20 | 1987-09-22 | Stauffer Chemical Company | Process for the production of acylated 1,3-dicarbonyl compounds |
| US4797147A (en) * | 1986-06-09 | 1989-01-10 | Stauffer Chemical Company | Herbicidal method and composition utilizing certain 5-(2-substituted benzoyl)-barbituric acids |
| US4938796A (en) * | 1987-07-06 | 1990-07-03 | Ici Americas Inc. | Herbicidal compositions of acylated 1,3-dicarbonyl herbicides and antidotes therefor |
| DE4029565B9 (de) * | 1989-09-18 | 2005-03-10 | Fuji Photo Film Co Ltd | Elektrophotographisches Aufzeichnungsmaterial und elektrophotographischer Druckplattenvorläufer, die ein Phthalocyaninpigment und ein Thiobarbitursäurederivat enthalten |
| JP2588779B2 (ja) * | 1989-09-18 | 1997-03-12 | 富士写真フイルム株式会社 | 電子写真式製版用印刷原版 |
| JP2588780B2 (ja) * | 1989-09-26 | 1997-03-12 | 富士写真フイルム株式会社 | 電子写真感光体 |
| JPH03179361A (ja) * | 1989-12-07 | 1991-08-05 | Fuji Photo Film Co Ltd | 光導電性組成物およびそれを用いた電子写真感光材料 |
| US5141943A (en) * | 1990-04-12 | 1992-08-25 | Brown University Research Foundation | 5-benzyl barbiturate derivatives |
| NL9001075A (no) * | 1990-05-04 | 1991-12-02 | Duphar Int Res | |
| DK0517660T3 (da) * | 1991-06-05 | 1997-10-27 | Ciba Geigy Ag | Benzo-1,2,3-thiadiazol-derivater. |
| WO1996025402A1 (en) * | 1995-02-13 | 1996-08-22 | Gulliya Kirpal S | Novel uses for barbituric acid analogs |
| JPH10316608A (ja) * | 1997-05-14 | 1998-12-02 | Hoechst Yakuhin Kogyo Kk | ポリヒドロキシフェノール誘導体およびそれらからなる骨・軟骨疾患予防・治療剤 |
-
1998
- 1998-03-27 JP JP10100355A patent/JPH11279157A/ja active Pending
-
1999
- 1999-03-23 WO PCT/IB1999/000961 patent/WO1999050252A2/en not_active Ceased
- 1999-03-23 SK SK1403-2000A patent/SK14032000A3/sk unknown
- 1999-03-23 CN CN99804571A patent/CN1295565A/zh active Pending
- 1999-03-23 BR BR9909139-9A patent/BR9909139A/pt not_active IP Right Cessation
- 1999-03-23 NZ NZ506616A patent/NZ506616A/xx unknown
- 1999-03-23 PL PL99343433A patent/PL343433A1/xx unknown
- 1999-03-23 KR KR1020007010669A patent/KR20010042182A/ko not_active Withdrawn
- 1999-03-23 CA CA002324584A patent/CA2324584A1/en not_active Abandoned
- 1999-03-23 US US09/647,280 patent/US6498164B1/en not_active Expired - Fee Related
- 1999-03-23 EP EP99919495A patent/EP1064269A1/en not_active Withdrawn
- 1999-03-23 AU AU37260/99A patent/AU759249B2/en not_active Ceased
- 1999-03-23 HU HU0101505A patent/HUP0101505A3/hu unknown
- 1999-03-23 EA EA200000992A patent/EA200000992A1/ru unknown
- 1999-03-23 IL IL13843399A patent/IL138433A0/xx unknown
- 1999-03-23 YU YU57800A patent/YU57800A/sh unknown
- 1999-03-23 CZ CZ20003460A patent/CZ20003460A3/cs unknown
- 1999-03-23 TR TR2000/02785T patent/TR200002785T2/xx unknown
-
2000
- 2000-08-29 ZA ZA200004473A patent/ZA200004473B/xx unknown
- 2000-09-26 NO NO20004798A patent/NO20004798L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU3726099A (en) | 1999-10-18 |
| ZA200004473B (en) | 2001-05-30 |
| HUP0101505A2 (hu) | 2002-03-28 |
| NZ506616A (en) | 2003-04-29 |
| IL138433A0 (en) | 2001-10-31 |
| JPH11279157A (ja) | 1999-10-12 |
| EA200000992A1 (ru) | 2001-06-25 |
| YU57800A (sh) | 2002-10-18 |
| KR20010042182A (ko) | 2001-05-25 |
| BR9909139A (pt) | 2000-12-05 |
| NO20004798D0 (no) | 2000-09-26 |
| SK14032000A3 (sk) | 2001-03-12 |
| EP1064269A1 (en) | 2001-01-03 |
| PL343433A1 (en) | 2001-08-13 |
| TR200002785T2 (tr) | 2001-02-21 |
| WO1999050252A2 (en) | 1999-10-07 |
| CN1295565A (zh) | 2001-05-16 |
| CZ20003460A3 (cs) | 2001-08-15 |
| US6498164B1 (en) | 2002-12-24 |
| AU759249B2 (en) | 2003-04-10 |
| HUP0101505A3 (en) | 2002-06-28 |
| WO1999050252A3 (en) | 2000-01-13 |
| CA2324584A1 (en) | 1999-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20020968D0 (no) | Glukopyranosyloksypyrazolderivater, medisinske sammensetninger inneholdende det samme og intermediater forfremstillingen derav | |
| DE69521424D1 (de) | Benzofuran derivate und ihre verwendung als inhibitoren der knochenresorption | |
| NO20051010L (no) | Triazolderivater som transformerende vekst faktor (TGF) inhibitorer | |
| NO324249B1 (no) | Glykopyranosyloksybenzylbenzenderivater, medisinske sammensetninger inneholdende slike, samt intermediater til fremstilling av derivatene | |
| DE60012751D1 (de) | Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz | |
| DE69935718D1 (de) | Antidiabetische medikamente | |
| DE69524598D1 (de) | Kondensierte imidazolderivate, ihre herstellung und verwendung | |
| AU7517400A (en) | N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent | |
| ATE316962T1 (de) | Pyrimidin-derivate als selective inhibitoren von cox-2 | |
| NO20026014D0 (no) | Vitamin D-derivater | |
| ATE223411T1 (de) | 1-methylcarbapenem-derivate | |
| DE69828197D1 (de) | Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut | |
| NO20004798L (no) | Barbitursyrederivat og forebyggende og terapeutisk middel for ben og brusk inneholdende det samme | |
| EP0852226A4 (en) | Pyrimidine derivatives | |
| ES2158290T3 (es) | Derivados de tiazolidinona opticamente activos. | |
| NO985298L (no) | Polyhydroksyfenolderivater og forebyggende og terapeutiske midler for ben- | |
| ATE305783T1 (de) | Verwendung von diaminotrifluoromethylpyridinderivaten für die prevention und behandlung von lebererkrankungen | |
| ATE278701T1 (de) | Malto-oligosaccharide und deren verwendung | |
| WO2005025492A3 (en) | Novel compositions, pharmaceutical compositions, and methods for the treatment and prevention of heart disease |